Hypereosinophilic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Sep 2022	66	Global Markets Direct	ASDR-610420

Published: Sep 2022 - Pages : 66 - Publisher : Global Markets Direct - Report code : ASDR-610420

A. Menarini Industrie Farmaceutiche Riunite Srl
Areteia Therapeutics Inc
GSK plc
Incyte Corp
Kyowa Kirin Co Ltd
Nexeos Bio